Sulforaphane Side Effects

Reported Sulforaphane side effects

Sulforaphane is remarkably well-tolerated in both dietary and supplemental contexts. Common and uncommon adverse effects include: Gastrointestinal effects (most common): Mild gas, bloating, or loose stools occur in 5-15% of users, particularly when starting supplementation or with broccoli sprout consumption. These effects are typically due to the high fiber content of whole sprouts or the stool-loosening effect of glucosinolate metabolites. Usually transient; resolve with continued use or by dividing dose across meals. Distinctive odor/taste: Sulforaphane and its metabolites are volatile sulfur compounds and can produce mild body odor changes or a distinctive taste perception. Most users find this mild and well-tolerated; it typically does not affect social function. Flatulence: Broccoli sprout consumption in particular can produce flatulence due to fiber content. Supplement forms generally produce less. Headache: Mild headache reported occasionally; typically transient. Nausea: Mild nausea can occur particularly when taking supplements on empty stomach; food co-administration resolves. Goitrogenic concerns (theoretical): Glucosinolates from cruciferous vegetables can theoretically produce goitrogenic effects by interfering with iodine uptake. Clinical significance in humans at dietary and typical supplementation doses is minimal — thyroid function is maintained normally in consumers of substantial cruciferous vegetables. Individuals with iodine deficiency, pre-existing thyroid disease, or taking thyroid medication should use caution, ensure adequate iodine intake, and consider monitoring thyroid function if using very high doses. Drug interactions with glutathione-depleting medications: Sulforaphane enhances glutathione synthesis, which could theoretically interact with medications that rely on glutathione depletion for therapeutic effect (acetaminophen at toxic doses; some chemotherapy agents). Clinical significance at typical supplementation doses is modest. Interactions with anticoagulants: Sulforaphane has mild effects on platelet function. Clinical significance is likely modest but warrants awareness in patients on warfarin or other anticoagulants. Interactions with cytochrome P450 enzyme-metabolized medications: Sulforaphane upregulates many phase I and phase II metabolizing enzymes, which could theoretically alter the disposition of medications metabolized by these enzymes. Clinical relevance at typical supplementation doses is likely modest but warrants awareness for narrow-therapeutic-index medications. Pregnancy and lactation: Dietary intake of broccoli and other cruciferous vegetables is safe and encouraged during pregnancy. Pharmaceutical-dose sulforaphane supplementation during pregnancy has not been rigorously studied; moderate supplemental doses are likely safe based on the extensive dietary safety record, but formal safety establishment is lacking. Lactation similarly — dietary sources are encouraged, supplementation not rigorously established. Pediatric use: Dietary broccoli consumption is safe for children. The Singh 2014 autism trial demonstrated safety of sulforaphane at 9-27 mg/day in adolescents and young adults. Broccoli sprout extract products are marketed with pediatric dosing in some cases; consult pediatricians. Body odor and sweat: Some users report a mild change in body odor (sulfur-like) particularly with high dosing. This reflects sulforaphane metabolite excretion through sweat. Usually not socially problematic. Urine odor: Mild sulfurous odor to urine is common and benign. Halitosis: Some users report sulfur-like breath with high doses. Improves with reduced dose or chlorophyll supplementation. Long-term safety: The extensive dietary safety record of cruciferous vegetables supports long-term safety of sulforaphane exposure at physiologic levels. Long-term (>1 year) supplementation data at pharmaceutical doses are less extensive but available from multiple clinical trials without concerning signals. Allergic reactions: Uncommon; possible with Brassicaceae family allergies. Patients with known broccoli or cruciferous vegetable allergies should avoid sulforaphane supplementation. Overall tolerability grade: Excellent — sulforaphane is among the best-tolerated supplement categories with a strong dietary safety foundation. Most users experience no clinically significant adverse effects at doses up to 200+ mg glucoraphanin daily. Primary cautions relate to individuals with thyroid disease (goitrogenic potential theoretical concern), those on warfarin (mild antiplatelet), or with cruciferous vegetable allergies.

When to continue, reduce, or stop Sulforaphane

Sulforaphane contraindications

Absolute contraindications: Known allergy to broccoli or Brassicaceae family (cruciferous vegetables): Some individuals have cross-reactivity between cruciferous vegetables; allergic individuals should avoid sulforaphane supplementation. Severe iodine deficiency with hypothyroid symptoms: Theoretical goitrogenic concern at high doses; ensure adequate iodine status first (urinary iodine testing; iodine supplementation if deficient). Relative contraindications (discuss with physician before use): Pre-existing thyroid disease (hyperthyroidism, hypothyroidism, Hashimoto's, Graves'): The goitrogenic potential of glucosinolates is theoretical at typical supplementation doses, but warrants monitoring particularly at high doses. Hypothyroid patients on thyroid medication should monitor thyroid function if adding sulforaphane at moderate-to-high doses. Anticoagulation therapy (warfarin, DOACs, clopidogrel): Mild antiplatelet effects may improve bleeding risk; physician discussion recommended at high doses. Active cancer under chemotherapy: Some tyrosine kinase inhibitors and other chemotherapy agents may interact with sulforaphane's effects on phase I/II metabolizing enzymes; discuss with oncology team. Pregnancy (high-dose supplementation): Dietary cruciferous vegetables are encouraged; pharmaceutical-dose supplementation should be avoided without physician supervision. Lactation (high-dose supplementation): Dietary sources encouraged; pharmaceutical-dose supplementation avoid without physician supervision. Upcoming surgical procedures: Discontinue sulforaphane 7-10 days before surgery to minimize any antiplatelet effect. Severe renal or hepatic impairment: Limited clinical data; theoretical concerns about altered metabolism. Concurrent use of acetaminophen at high doses or frequent therapeutic doses: Theoretical interaction via glutathione modulation. Caution populations: Adults over 75 years: Consider starting at lower doses and titrating based on tolerance. Iodine-deficient individuals: Ensure adequate iodine status; consider iodine supplementation alongside cruciferous-heavy diet. Children and adolescents: For specific clinical applications (autism), pediatric-supervised dosing; general supplementation for children is not established. Polypharmacy users: Multiple concurrent medications with narrow therapeutic indices warrant physician review given sulforaphane's effects on drug-metabolizing enzymes. Drug interactions requiring monitoring: Warfarin (mild antiplatelet at high doses) Levothyroxine and thyroid medications (theoretical thyroid effects at high doses) Acetaminophen at therapeutic or toxic doses (theoretical glutathione interaction) Some chemotherapy agents (CYP modulation concerns) Antihypertensive medications (theoretical modest effects) Statins (no specific concern but lipid monitoring is standard) Discontinue immediately and seek medical attention if: Severe allergic reaction (rash, difficulty breathing, facial swelling) Severe persistent gastrointestinal symptoms New thyroid symptoms (hypothyroid symptoms, neck swelling) Significant unexplained bleeding or bruising

Why vendor quality drives Sulforaphane side-effect frequency

Research-compound communities consistently report that adverse-event frequency tracks with source quality. Three reasons: (1) impurity profiles vary by lab (residual synthesis byproducts can trigger reactions); (2) mislabeled mass means actual dose can be 50-150% of stated dose; (3) reconstitution-grade water and capping methodology affect long-term storage stability. COA-verified vendors with published HPLC data minimize all three failure modes. Check a vendor's COA record and Trust Score before you buy.

Sulforaphane side effects FAQ

Research-use disclaimer. All safety information on this page summarizes published research literature and community-reported reactions. It is not medical advice and not authorization for human consumption. Always consult a licensed practitioner before any compound enters a clinical context. Compounds linked from this page are sold for research-use only.
Affiliate disclosure. See our affiliate disclosure .